Results 171 to 180 of about 74,999 (298)

Future use of the Glasgow alcoholic hepatitis score

open access: yes, 2006
The overall death rate in the study was 23% at 28 days and the death rate of patients with a DFS >32 was 29% at 28 days in the derivation population.
Guha, I.N., Rosenberg, W.M.
core  

CLEC14A correlates with neutrophil infiltration in hepatocellular carcinoma and mediates neutrophil recruitment across liver endothelial cells

open access: yesThe Journal of Pathology, EarlyView.
Abstract Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related deaths globally, and cases are predicted to rise dramatically over the next few years. Overcoming the immune microenvironment in HCC remains a challenge, and innate immune populations such as tumour‐associated neutrophils can potentially impair the success of immunotherapy ...
Joanne M O'Rourke   +24 more
wiley   +1 more source

Severe acute alcoholic hepatitis: an audit of medical treatment.

open access: yes, 2002
Despite advances in treatment, severe alcoholic hepatitis is still associated with a high mortality rate of 30% to 40%. Nutritional support and steroids in selected patients are believed to improve prognosis.
O'Keefe, C, McCormick, PA
core  

Endoscopic Treatment for Esophagogastric Variceal Bleeding in Patients With Acute‐on‐Chronic Liver Failure: An Observational Study

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
In patients with acute‐on‐chronic liver failure (ACLF), esophagogastric variceal bleeding (EGVB) represents a critical complication associated with high short‐term mortality. This study evaluated the efficacy of endoscopic treatment in this specific population and identified prognostic factors associated with 6‐week rebleeding and mortality.
Yanan Sun   +7 more
wiley   +1 more source

Metastasis of Hepatocellular Carcinoma to the Urinary Bladder: A Case Report and Literature Review. [PDF]

open access: yesIJU Case Rep
Fukagawa E   +6 more
europepmc   +1 more source

Alcohol-associated hepatitis

open access: yesCanadian Medical Association Journal, 2023
Jugnundan, Sechiv   +2 more
openaire   +2 more sources

When Fat Goes Astray: Your Liver and Pancreas Get Into Trouble

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
Metabolic dysfunction‐associated steatotic liver disease (MASLD) and intrapancreatic fat deposition (IPFD) are both common manifestations of ectopic fat accumulation. Although they share multiple risk factors, they also show notable differences in pathological features, standardization of diagnosis, and research maturity.
Yuying Chen   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy